Detailed price information for Fate Therapeutics (FATE-Q) from The Globe and Mail including charting and trades.

Three themes defined the energy industry in 2025: data centres' rising power demand, tariffs disrupting supply chains, and ...

The new year will mean the arrival of more than 20 new state laws limiting extra fees landlords can charge, expanding ...

One of the most exciting advances in cancer treatments in the past decade is the development of T cell immunotherapies, in which a patient's own immune system is trained to recognize and attack ...

IMA203CD8 is a second-generation PRAME cell therapy with enhanced pharmacology in ongoing Phase 1a dose escalationManageable tolerability across ...

Adding erythropoietin to hydroxyurea treatment could significantly improve quality of life for patients with sickle cell ...

In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the ...

Inhibiting prolactin receptor (PRLR) signaling with the ABS-201 anti-PRLR antibody promotes human hair follicle growth ex vivoHuman ex vivo data ...

Nektar Therapeutics (NASDAQ:NKTR) reported results from its Phase 2b REZOLVE-AA study evaluating rezpegaldesleukin in patients with severe to very severe alopecia areata, with the trial narrowly ...

One of the most exciting advances in cancer treatments in the past decade is the development of T cell immunotherapies, in which a patient's own immune system is trained to recognize and attack ...

The tiny pantheon known as the Asgard archaea bear traits that hint at how plants, animals and fungi emerged on Earth.

An international research team involving the German Primate Center – Leibniz Institute for Primate Research (DPZ), Hannover ...